BioInvent International AB - Company Profile
Powered by 
All the sales intelligence you need on BioInvent International AB in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how BioInvent International AB fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with BioInvent International AB.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on BioInvent International AB patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230058227A1 | Application | NOVEL ANTIBODIES AND COMBINED USE OF A TREG DEPLETING ANTIBODY AND AN IMMUNOSTIMULATORY ANTIBODY | A61K2039/507; C07K16/2815; C07K16/2878 | February 23, 2023 |
| WO2021245238A9 | Search Report | IMPROVING ANTIBODY TOLERABILITY ASSOCIATED WITH INTRAVENOUS ADMINISTRATION | A61K2039/505; A61K2039/54; A61K2039/545; A61K9/0019; A61P35/00; C07K14/721; C07K16/283 | February 02, 2023 |
| AU2021286202A1 | Application | Improving antibody tolerability associated with intravenous administration | A61K2039/505; A61K2039/54; A61K2039/545; A61K9/0019; A61P35/00; C07K14/721; C07K16/283 | January 19, 2023 |
| EP4103613A1 | Application | LILRB3-ANTIKÖRPERMOLEKÜLE UND VERWENDUNGEN DAVON | A61K2039/505; A61P37/06; C07K16/2803; C07K2317/24; C07K2317/622; C07K2317/75; C07K2317/92 | December 21, 2022 |
| KR1020220154686A | Application | LILRB3 항체 분자 및 이의 용도 | A61K2039/505; A61P37/06; C07K16/2803; C07K2317/24; C07K2317/622; C07K2317/75; C07K2317/92 | November 22, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer